Cargando…

COT-02 The opening of tumor treating fields with online support system

Background: EF-14 trial showed the efficacy of tumor treating fields (TTF), and TTF was approved as a standard therapy for glioblastoma. In TTF opening, Device Support Specialist (DSS) should explain how to use it for the patient and family. However no DSS does always stay in our Yamaguchi prefectur...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadahiro, Hirokazu, Sugimoto, Kazutaka, Nomura, Sadahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699128/
http://dx.doi.org/10.1093/noajnl/vdaa143.092
_version_ 1783615978103373824
author Sadahiro, Hirokazu
Sugimoto, Kazutaka
Nomura, Sadahiro
author_facet Sadahiro, Hirokazu
Sugimoto, Kazutaka
Nomura, Sadahiro
author_sort Sadahiro, Hirokazu
collection PubMed
description Background: EF-14 trial showed the efficacy of tumor treating fields (TTF), and TTF was approved as a standard therapy for glioblastoma. In TTF opening, Device Support Specialist (DSS) should explain how to use it for the patient and family. However no DSS does always stay in our Yamaguchi prefecture, and DSS has to come to our hospital across other prefectures. On the other hand, COVID-19 infection is still spreading and it is sometimes tough to move from a big city to countryside. Here, we would present the first experience of TTF opening with online DSS support. A case report: A 68 years old man had right hemiparesis. MRI showed multiple lesions in the left hemisphere, and biopsy showed glioblastoma. After 1 month from chemo and radiotherapy, TTF was introduced. DSS from Tokyo explained how to use TTF via PC camera with TV monitor. A skilled neurosurgeon and special nurse also helped them in front of him. His head and the attached array were well checked from DSS with PC camera moving around him. Everything was smooth and he started TTF. Conclusion: Online medicine should be absolutely spreading. In countryside, it is hard that DSS comes to our hospital from a big city. TTF opening could be favorable via online system with skilled medical stuffs.
format Online
Article
Text
id pubmed-7699128
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-76991282020-12-02 COT-02 The opening of tumor treating fields with online support system Sadahiro, Hirokazu Sugimoto, Kazutaka Nomura, Sadahiro Neurooncol Adv Supplement Abstracts Background: EF-14 trial showed the efficacy of tumor treating fields (TTF), and TTF was approved as a standard therapy for glioblastoma. In TTF opening, Device Support Specialist (DSS) should explain how to use it for the patient and family. However no DSS does always stay in our Yamaguchi prefecture, and DSS has to come to our hospital across other prefectures. On the other hand, COVID-19 infection is still spreading and it is sometimes tough to move from a big city to countryside. Here, we would present the first experience of TTF opening with online DSS support. A case report: A 68 years old man had right hemiparesis. MRI showed multiple lesions in the left hemisphere, and biopsy showed glioblastoma. After 1 month from chemo and radiotherapy, TTF was introduced. DSS from Tokyo explained how to use TTF via PC camera with TV monitor. A skilled neurosurgeon and special nurse also helped them in front of him. His head and the attached array were well checked from DSS with PC camera moving around him. Everything was smooth and he started TTF. Conclusion: Online medicine should be absolutely spreading. In countryside, it is hard that DSS comes to our hospital from a big city. TTF opening could be favorable via online system with skilled medical stuffs. Oxford University Press 2020-11-28 /pmc/articles/PMC7699128/ http://dx.doi.org/10.1093/noajnl/vdaa143.092 Text en © The Author(s) 2020. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Supplement Abstracts
Sadahiro, Hirokazu
Sugimoto, Kazutaka
Nomura, Sadahiro
COT-02 The opening of tumor treating fields with online support system
title COT-02 The opening of tumor treating fields with online support system
title_full COT-02 The opening of tumor treating fields with online support system
title_fullStr COT-02 The opening of tumor treating fields with online support system
title_full_unstemmed COT-02 The opening of tumor treating fields with online support system
title_short COT-02 The opening of tumor treating fields with online support system
title_sort cot-02 the opening of tumor treating fields with online support system
topic Supplement Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699128/
http://dx.doi.org/10.1093/noajnl/vdaa143.092
work_keys_str_mv AT sadahirohirokazu cot02theopeningoftumortreatingfieldswithonlinesupportsystem
AT sugimotokazutaka cot02theopeningoftumortreatingfieldswithonlinesupportsystem
AT nomurasadahiro cot02theopeningoftumortreatingfieldswithonlinesupportsystem